Clinical Nutrition Products: World Markets, 3rd Edition
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition:
- Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)
- Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
- Parenteral Nutrition
Coverage of Issues and Trends in Clinical Nutrition
There are several issues and trends that are impacting the clinical nutrition market, including:
- Wound Care Applications
- Reimbursement of Nutrition Products
- Food Programs
- Nutrition and Education
- DHA and ANA Additives
- Counterfeit Infant Formulas
- Recalled Infant Formulas
- Acquisition, Mergers and Alliances
- Technology Applications
Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. The majority of competitive participation is in developed regions such as the United States, Western Europe, and Japan. However, many companies are expanding into less developed regions, intensifying competition in less tapped markets. China, for example, is among the expanding competitive regions as companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:
- Abbott Laboratories
- Baxter International
- B. Braun
- Fresenius Kabi
- Mead Johnson
- PBM Products
For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level.
The base year for data was 2008. Historical data was provided for the years 2006 and 2007, with forecast data provided for 2009 through 2013. Compound annual growth rates (CAGRs) are provided for the 2006-2008, 2008-2013 and 2006-2013 periods for each industry segment covered. Competitive analysis is provided for the year 2008. The forecasted market analysis for 2009-2013 was based on demographic trends, new developments, and global expansion.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.